The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial, multicenter, first line paclitaxel-avelumab treatment for inoperable angiosarcoma.
 
Hye Ryeon Kim
No Relationships to Disclose
 
Miso Kim
Honoraria - Astellas Pharma; Merck; Novartis; Yuhan
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; Boryung; Bristol-Myers Squibb/Ono Pharmaceutical; Eisai; Ipsen; Janssen; Merck; MSD; Pfizer; Roche; Yuhan
 
Jeong Eun Kim
Consulting or Advisory Role - Roche/Genentech
 
Hyojeong Kim
No Relationships to Disclose
 
Yu Jung Kim
No Relationships to Disclose
 
Myoung Joo Kang
No Relationships to Disclose
 
Kwonoh Park
No Relationships to Disclose
 
Woo Kyun Bae
No Relationships to Disclose
 
Jung Yong Hong
No Relationships to Disclose
 
Sung Yong Oh
No Relationships to Disclose